Golden State Equity Partners Mirum Pharmaceuticals, Inc. Transaction History
Golden State Equity Partners
- $522 Million
- Q2 2025
A detailed history of Golden State Equity Partners transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Golden State Equity Partners holds 19,380 shares of MIRM stock, worth $997,876. This represents 0.19% of its overall portfolio holdings.
Number of Shares
19,380
Previous 19,380
-0.0%
Holding current value
$997,876
Previous $873,000
12.94%
% of portfolio
0.19%
Previous 0.18%
Shares
9 transactions
Others Institutions Holding MIRM
# of Institutions
227Shares Held
55.4MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$350 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$245 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$167 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$144 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$131 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.89B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...